Pituitary Adenoma: Clinical Trials

75 trials for Pituitary Adenoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

30 completed, 16 recruiting, 15 unknown, 5 not yet recruiting. 34 Not applicable, 6 Phase 4, 4 Phase 1, 3 Early Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable34Completed 15, Unknown 10, Recruiting 5, Terminated 2, Enrolling by invitation 1, Not yet recruiting 1
Phase 46Recruiting 3, Completed 2, Enrolling by invitation 1
Phase 14Active not recruiting 1, Completed 1, Recruiting 1, Unknown 1
Early Phase 13Recruiting 2, Not yet recruiting 1
Phase 32Completed 1, Not yet recruiting 1

Follow Pituitary Adenoma: new trials by email Literature Review of Pituitary Adenoma trials Research Report on Pituitary Adenoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PRESTO: A Phase III Randomised Controlled Trial of Dose-escalated Proton Beam Therapy Versus Standard of Care Radiotherapy for Functioning Pituitary Tumours
Standard dose Intensity-Modulated Radiation Therapy (IMRT), Standard dose Proton Beam Therapy (PBT), Escalated dose Proton Beam Therapy (PBT) - Acromegaly Due to Pituitary Adenoma, Cushing's Disease
Phase 3Not yet recruitingUniversity College, London822026-09-012026-10-01
Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Panitumumab-IRDye800 - Meningioma, Glioblastoma
Early Phase 1RecruitingEben Rosenthal302026-07-072026-10-16
AI in Endoscopic Transsphenoidal Surgery
Live intra-op AI analysis of endoscopic video feed, with output displayed on supplementary monitor - Pituitary Adenoma
Early Phase 1Not yet recruitingUniversity College, London302026-06-012026-05-05
Standardized Patient Education in Pituitary Surgery
Standardized Pituitary Training - Pituitary Adenoma
Not applicableNot yet recruitingUludag University1022026-06-012026-06-01
FET PET/CT Imaging To Localize Pituitary Adenomas In Cushing Disease
Fluoro-O-(2) fluoroethyl-L-tyrosine (FET) PET - Cushing Disease, Pituitary Adenoma
Early Phase 1RecruitingMayo Clinic502026-04-272026-10-30
DDAVP for Pituitary Adenoma
Desmopressin acetate - Cushing's Disease, Pituitary Adenoma
Not applicableRecruitingNational Institute of Neurological Disorders and Stroke (NINDS)222026-03-092026-04-09
Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery
Anti-fog suction device-a 4 Fr multi-channel silicone catheter - Pituitary Adenoma, Craniopharyngioma
Not applicableRecruitingWest China Hospital202026-03-012026-06-30
Use of [18F] Fluoroethyl-L-tyrosine PET/MRI for Identifying Small Functional Pituitary Adenomas
FET-PET/MRI - Pituitary Adenoma
Phase 1RecruitingMayo Clinic52026-01-082026-03-09
Prediction Model for Postoperative Headache After Transsphenoidal Pituitary Surgery
Transsphenoidal Pituitary Surgery - Headache, Pituitary Adenoma
Active not recruitingBeijing Tiantan Hospital5002026-01-012026-03-03
Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region.
Standard-of-care PET/CT, NeuroEXPLORER - Dementia, Movement Disorders
Not applicableEnrolling by invitationprof. dr. Koen Van Laere16002025-09-302026-05-19
Proton Versus Photon Radiotherapy in Adults With Primary Brain Tumors
Proton Beam Therapy, Photon Radiotherapy - Primary Brain Tumors, Diffuse Glioma
Not applicableRecruitingTata Memorial Centre1562025-07-012025-09-16
The Impact of Endoscopic Endonasal Skull Base Surgery on Olfaction
Endoscopic endonasal skull base surgery - Meningioma, Pituitary Disease
RecruitingUniversitaire Ziekenhuizen KU Leuven1542025-03-182025-04-23
A Twenty-years' Experience in Pituitary Disease.
Frequency of disease recurrence - Pituitary Adenoma, Pituitary Cancer
RecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS16002025-03-102025-05-15
Hydrocortisone in Hormone Replacement Therapy for Large Pituitary Neuroendocrine Tumors
Hormone replacement therapy, Placebo - Pituitary Adenoma, Pituitary Neuroendocrine Tumor
Phase 4RecruitingBeijing Tiantan Hospital8822024-12-042025-01-14
Osilodrostat Therapy and 11C-methionine PET to Improve Corticotroph Adenoma Detection
11C-Methionine PET/CT - Cushing's Disease, Hypercortisolism
Not yet recruitingImperial College London152024-12-032024-12-03
Effect of Foot Bath on Anxiety and Physiological Parameters
Warm water foot bath - Pituitary Adenoma, Surgery
Not applicableCompletedTrakya University1002024-09-252026-04-21
Molecular Pituitary Imaging Using 18F-FET PET
18F-Fluoro-ethyl-tyrosine (FET) PET - Pituitary Adenoma
Not applicableRecruitingUniversity of Cambridge202024-09-032026-01-06
Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models
Endocrine Disorders, Adiposity
Not yet recruitingIRCCS San Raffaele2002024-07-012024-06-11
Evaluation of Intraoperative Contrast Enhanced Ultrasound for the Identification of Pituitary Adenoma in Cushing's Disease Compared to Other Pituitary Tumors
Contrast enhanced pituitary magnetic resonance imaging (MRI), Contrast enhanced ultrasound, Non-Contrast Ultrasound - Pituitary Adenoma, Cushing Disease
RecruitingMayo Clinic1102024-06-192026-01-13
Cabergoline in the Management of Nonfunctioning Pituitary Adenoma
Cabergoline 0.5 MG - Pituitary Adenoma, MRI
Phase 4Enrolling by invitationNational Taiwan University Hospital302024-05-202025-06-24

Showing 20 of 75. Sign in to see all of them.

Narrower conditions

Pituitary Neoplasms (75)  ·  Meningioma (7)  ·  Pituitary Diseases (7)  ·  Brain Neoplasms (6)  ·  Pituitary ACTH Hypersecretion (5)  ·  Cushing Syndrome (4)  ·  Acromegaly (3)  ·  Adenoma (2)  ·  Craniopharyngioma (2)  ·  Medulloblastoma (2)  ·  Neuroblastoma (2)  ·  Neuroendocrine Tumors (2)  ·  Paraganglioma (2)  ·  Prolactinoma (2)  ·  ACTH-Secreting Pituitary Adenoma (1)

Broader conditions

Brain Diseases (75)  ·  Central Nervous System Diseases (75)  ·  Endocrine Gland Neoplasms (75)  ·  Hypothalamic Diseases (75)  ·  Hypothalamic Neoplasms (75)  ·  Neoplasms by Site (75)  ·  Nervous System Diseases (75)  ·  Nervous System Neoplasms (75)  ·  Supratentorial Neoplasms (75)  ·  Central Nervous System Neoplasms (74)  ·  Endocrine System Diseases (74)  ·  Neoplasms (74)  ·  Brain Neoplasms (69)  ·  Pituitary Diseases (68)  ·  Neoplasms by Histologic Type (16)

Interventions

Cabergoline (3)  ·  Hydrocortisone (2)  ·  Propofol (2)  ·  Proton Therapy (2)  ·  Sevoflurane (2)  ·  Surgical Procedures, Operative (2)  ·  2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1)  ·  Aminolevulinic Acid (1)  ·  Anti-Inflammatory Agents, Non-Steroidal (1)  ·  Blood Specimen Collection (1)  ·  Cefdinir (1)  ·  Continuous Glucose Monitoring (1)  ·  Critical Pathways (1)  ·  Deamino Arginine Vasopressin (1)  ·  Desflurane (1)

Sponsors

Peking Union Medical College Hospital (4)  ·  St. Joseph's Hospital and Medical Center, Phoenix (4)  ·  Beijing Tiantan Hospital (3)  ·  Federico II University (3)  ·  Huashan Hospital (3)  ·  Mayo Clinic (3)  ·  University College, London (3)  ·  University Hospital, Basel, Switzerland (3)  ·  Seoul National University Hospital (2)  ·  Universitaire Ziekenhuizen KU Leuven (2)  ·  Affiliated Hospital of Nantong University (1)  ·  British Columbia Cancer Agency (1)  ·  Cardiff University (1)  ·  Central Hospital, Nancy, France (1)  ·  Centre Hospitalier Universitaire de Nice (1)

Countries

United States (17)  ·  China (14)  ·  Italy (6)  ·  Switzerland (4)  ·  United Kingdom (4)  ·  Belgium (3)  ·  Canada (3)  ·  France (3)  ·  Germany (3)  ·  Netherlands (3)  ·  South Korea (3)  ·  Turkey (Türkiye) (3)  ·  Czechia (2)  ·  Taiwan (2)  ·  Austria (1)

Top investigators

Bing Xing, MD (3)  ·  Gilda Cennamo (3)  ·  Wei Lian, MD (3)  ·  Andrew Little, MD (2)  ·  Ahmad M. Al-Arman (1)  ·  Aled Rees, MB BCh, PhD (1)  ·  Andrej Pala, MD (1)  ·  Andrew S Little, MD (1)  ·  Andrew S. Little, MD (1)  ·  Carlo Serra, MD (1)  ·  Chul-Kee Park, MD PhD (1)  ·  David M Kleinberg, MD (1)  ·  Deborah P Merke, M.D. (1)  ·  Derek Johnson, MD (1)

Results publications

PMID 16509142, PMID 1738293, PMID 17695407, PMID 17862444, PMID 18780796, PMID 19240574, PMID 19970261, PMID 21748460, PMID 22154461, PMID 22863387, PMID 23662829, PMID 25418156, PMID 25839931, PMID 25884256, PMID 25923040, PMID 26473774, PMID 27150495, PMID 27864853, PMID 28820308, PMID 28952907, PMID 29297053, PMID 30144606, PMID 30215565, PMID 30540568, PMID 30649445, PMID 30901746, PMID 31079156, PMID 31377966, PMID 31731279, PMID 31832214, PMID 31857533, PMID 32893266, PMID 33068429, PMID 34620658, PMID 35275019, PMID 35661809, PMID 35954244, PMID 36383383, PMID 38274233, PMID 38498406, PMID 38553990, PMID 38918132, PMID 38963694, PMID 39202235, PMID 39390132, PMID 39852769, PMID 40760415, PMID 41689093

NIH funding

2018 (1), R01NS070600 (1)